Gene · 80320
Papers2,366
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,366
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of Accuracy in Calculation of Absorbed Dose to the Kidneys Following Radioligand Therapy with 177Lu-DKFZ-PSMA-617 by Two Different Background Correction Methods. | Indian J Nucl Med | 2022 | 35982806 | PubTator, text mining | PubMed |
| Acupuncture as a Complementary Therapy for Cancer-Induced Bone Pain: A Systematic Review and Meta-Analysis. | Front Pain Res (Lausanne) | 2022 | 35978992 | PubTator, text mining | PubMed |
| APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. | Adv Sci (Weinh) | 2022 | 35975461 | PubTator, text mining | PubMed |
| Brain-specific genes contribute to chronic but not to acute back pain. | Pain Rep | 2022 | 35975136 | PubTator, text mining | PubMed |
| Evaluation of the efficacy and safety of intradermal needle therapy on the sleep quality of patients following laparoscopic hysterectomy: study protocol for a randomized controlled trial. | Ann Transl Med | 2022 | 35965821 | PubTator, text mining | PubMed |
| Binding Domain Characterization of Growth Hormone Secretagogue Receptor. | J Transl Int Med | 2022 | 35959447 | PubTator, text mining | PubMed |
| A randomised, pragmatic clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy Induced peripheral Neuropathy (ACUFOCIN). | Eur J Oncol Nurs | 2022 | 35952460 | PubTator, text mining | PubMed |
| Spermidine Crosslinked Gellan Gum-Based "Hydrogel Nanofibers" as Potential Tool for the Treatment of Nervous Tissue Injuries: A Formulation Study. | Int J Nanomedicine | 2022 | 35942070 | PubTator, text mining | PubMed |
| The Big Three Perfectionism Scale-Short Form: An item response theory analysis of Italian workers. | Front Psychol | 2022 | 35936274 | PubTator, text mining | PubMed |
| Hermansky-Pudlak syndrome type 2: A rare cause of severe periodontitis in adolescents-A case study. | Front Pediatr | 2022 | 35928686 | PubTator, text mining | PubMed |
| The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA). | Front Pharmacol | 2022 | 35928267 | PubTator, text mining | PubMed |
| Positive strand RNA viruses differ in the constraints they place on the folding of their negative strand. | RNA | 2022 | 35918125 | PubTator, text mining | PubMed |
| DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach. | Theranostics | 2022 | 35910791 | PubTator, text mining | PubMed |
| An Intron c.103-3T>C Variant of the AMELX Gene Causes Combined Hypomineralized and Hypoplastic Type of Amelogenesis Imperfecta: Case Series and Review of the Literature | Genes (Basel) | 2022 | 35886055 | PubTator, text mining | PubMed |
| Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease. | Children (Basel) | 2022 | 35884060 | PubTator, text mining | PubMed |
| [Acupoint compatibility effect and mechanism of Shenmen (HT7) and Sanyinjiao (SP6) in improving daytime fatigue and sleepiness of insomnia]. | Zhen Ci Yan Jiu | 2022 | 35880281 | PubTator, text mining | PubMed |
| An Innovative Arteriovenous (AV) Loop Breast Cancer Model Tailored for Cancer Research. | Bioengineering (Basel) | 2022 | 35877331 | PubTator, text mining | PubMed |
| Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. | J Virol | 2022 | 35876526 | PubTator, text mining | PubMed |
| Caffeine Attenuates Electroacupuncture Effect on Pressure Pain Threshold and Tolerance in Healthy Individuals: A Randomized Controlled Trial. | Front Neurol | 2022 | 35873768 | PubTator, text mining | PubMed |
| Electro-mechanical coupling of KCNQ channels is a target of epilepsy-associated mutations and retigabine. | Sci Adv | 2022 | 35857840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80320/papers?page=19